Huge thanks to our amazing faculty for their time and expertise! 🙌 Next stop: Clinical Trials Bootcamp in Mar del Plata, Argentina! 🇦🇷 Stay tuned. 3/3
#ISGD #ClinicalTrials #Nephrology #GlomerularDisease #ESPN2026 #PediatricNephrology #CTB #nephtwitter

Resident immune cell neighborhoods associate with protein kinase pRIPK3 and fatty acid ligase FACL4 expression during cell injury in ANCA associated vasculitis and #lupusnephritis

doi.org/10.1016/j.kint.2026.07.031

#NephSky #MedSky #OpenAccess #glomerulardisease @yaleschoolofmed.bsky.social #AAV

Meeting Report
Outcomes from the International Society of Nephrology forum on complement therapeutics in C3 glomerulopathy and IgA nephropathy

doi.org/10.1016/j.kint.2026.08.007

#NephSky #MedSky #OpenAccess #C3G #C3Glomerulopathy #IgAN #IgANephropathy #ComplementSystem #GlomerularDisease

From podocyte biology to #glomerular medicine: the 15th International #Podocyte Conference 2025

doi.org/10.1016/j.kint.2026.07.026

#NephSky #MedSky @isgd.bsky.social #Podocyte2025 #ISGD #GlomerularDisease #KidneyResearch #RenalPath #TranslationalNephrology #OpenAccess

Managing IgA nephropathy goes beyond supportive care.

When do you escalate therapy? What factors matter most? This episode walks through it.

🎧 bit.ly/3DamjQ9 (Episode 056)

#Nephrology #GlomerularDisease